Next Genetic Center (NGC) in Istanbul is one of Turkey’s leading laboratories specialising in genetic disease diagnostics and personalised medicine for international markets. Since 2019, NGC has been using MGI platforms DNBSEQ-G400RS* and DNBSEQ-G50RS Genetic Sequencer* through local distributor Invitrotek, enabling high-quality, reliable, and efficient genomic testing.
Advanced Genetic Testing Capabilities
NGC routinely performs Whole Exome Sequencing, Tumor Mutation Burden, Liquid Biopsy, and Tumor Profiling, offering clinic-specific genetic solutions. Dr. Ahmet Uludağ, Co-founder of NGC, highlights that MGI platforms provide more stable, accurate, and efficient results than other NGS systems previously used, supporting streamlined workflows and faster turn-around times.
Seamless Integration and Third-Party Compatibility
MGI DNBSEQ-G400RS* supports flexible sequencing modes with an optimized flow cell system, while DNBSEQ-G50RS* offers a compact, cost-effective solution for smaller laboratories. Both systems are compatible with a wide range of third-party kits, improving flexibility, efficiency, and affordability in genetic testing.
Strong Local Support and Future Collaboration
NGC values the technical support provided by MGI and Invitrotek, ensuring smooth operation and reliable troubleshooting. Dr. Uludağ emphasises the ongoing partnership with MGI will enable continued innovation in oncology genetic applications and other areas of precision medicine, with opportunities to contribute to testing and validation of new kits.
About NGC
Founded in 2017, NGC offers modern genetic tests and methods with a focus on accessibility, quality, and reliability. The centre aims to provide cutting-edge genetic diagnostics for international markets, leveraging expert staff and advanced technology.
About Invitrotek
Invitrotek (IVT), established in 2009, is a sales and marketing company in Turkey specialising in molecular diagnostics and genetic testing. IVT provides technical support, training, and a robust distribution network to ensure high market penetration and reliable service.
Unless otherwise stated, all sequencers and reagents are unavailable in Germany, USA, Spain, UK, Hong Kong, Sweden, Belgium, and Italy.
